Ethical Compliance

PANACEA BIOTEC
Sector:
Healthcare
Industry:
Biotechnology
Market Cap Class:
small
Revenue
0.6%
Debt
1.7%
Liquidity
11.2%
Revenue
Debt
Liquidity
0.6%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
Vaccines | ₹359.59 |
Formulations | ₹199.58 |
Other Income | ₹14.05 |
Interest Income | ₹8.37 |
Questionable
INR Crores
Investment Gain | ₹3.38 |
Non Compliant
INR Crores
INR Crores
Revenue from Questionable Sources: | ₹3.38 |
Revenue from Non Compliant Sources: | ₹0.00 |
Total: | ₹3.38 |
Total Revenue: | ₹584.96 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹3.38
₹584.96
= 0.6%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.